Case ID: f-appx_282/html/0510-01.html
Source: Caselaw Access Project
Author: {"author": "PER CURIAM.", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

Arthur MCELROY, Appellant, v. JANSSEN PHARMACEUTICA, INC.; Janssen Pharmaceutica, N.V.; Eli Lilly Pharmaceutical, Co., Appellees.
    No. 07-2277.
    United States Court of Appeals, Eighth Circuit.
    July 1, 2008.
    Before WOLLMAN, RILEY, and GRUENDER, Circuit Judges.
   PER CURIAM.

Arthur McElroy appeals the district court’s Federal Rule of Civil Procedure 12(b)(6) dismissal of his pro se products-liability claims against Janssen Pharmaceutica, Inc. and Janssen Pharmaceutica, N.V. Upon de novo review, see Reis v. Walker, 491 F.3d 868, 870 (8th Cir.2007), we conclude that dismissal was proper for the reasons stated by the district court.

Accordingly, the judgment is affirmed, see 8th Cir. R. 47B, and appellees’ pending motion is denied. 
      
      . The Honorable Richard G. Kopf, United States District Judge for the District of Nebraska.
     
      
      . McElroy's claim against Eli Lilly Pharmaceutical Company is not at issue in this appeal.